Clearance of blood stream infections in patients receiving extracorporeal membrane oxygenation: a retrospective single-center cohort study

[1] Peek GJ(2009)Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial Lancet 374 1351-1363

[2] Mugford M(2017)Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention Int J Antimicrob Agents 50 9-16

[3] Tiruvoipati R(2001)Predictors of acquiring a nosocomial bloodstream infection on extracorporeal membrane oxygenation J Pediatr Surg 36 487-492

[4] Wilson A(2011)Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Clin Infect Dis 52 e18-55

[5] Allen E(2016) infections in adults and children Clin Infect Dis 62 e1-50

[6] Thalanany MM(2014)Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America Eur J Clin Microbiol Infect Dis 33 1675-1685

[7] Biffi S(2013)Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review Infect Control Hosp Epidemiol 34 24-30

[8] Di Bella S(2013)Infections acquired by adults who receive extracorporeal membrane oxygenation: risk factors and outcome Med Intensiva 37 468-475

[9] Scaravilli V(2012)Infections occurring in adult patients receiving mechanical circulatory support: the two-year experience of an Italian National Referral Tertiary Care Center Clin Infect Dis 55 1633-1641

[10] Peri AM(2021)Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation J Intensive Care Med 36 1053-1060

[1] Peek GJ(2009)Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial Lancet 374 1351-1363

[2] Mugford M(2017)Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention Int J Antimicrob Agents 50 9-16

[3] Tiruvoipati R(2001)Predictors of acquiring a nosocomial bloodstream infection on extracorporeal membrane oxygenation J Pediatr Surg 36 487-492

[4] Wilson A(2011)Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Clin Infect Dis 52 e18-55

[5] Allen E(2016) infections in adults and children Clin Infect Dis 62 e1-50

[6] Thalanany MM(2014)Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America Eur J Clin Microbiol Infect Dis 33 1675-1685

[7] Biffi S(2013)Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review Infect Control Hosp Epidemiol 34 24-30

[8] Di Bella S(2013)Infections acquired by adults who receive extracorporeal membrane oxygenation: risk factors and outcome Med Intensiva 37 468-475

[9] Scaravilli V(2012)Infections occurring in adult patients receiving mechanical circulatory support: the two-year experience of an Italian National Referral Tertiary Care Center Clin Infect Dis 55 1633-1641

[10] Peri AM(2021)Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation J Intensive Care Med 36 1053-1060